Lyell Immunopharma (LYEL) Return on Assets [ROA] (2021 - 2026)
Lyell Immunopharma (LYEL) reported Return on Assets [ROA] of -77.52% for Q2 2026, up 9.86 percentage points from -87.37% a year earlier but down 3.30 percentage points from the prior quarter.
Powered by 
Analysis
Lyell Immunopharma (LYEL) Return on Assets [ROA] (2021 - 2026) Analysis & Trends
For FY2025, Lyell Immunopharma posted Return on Assets [ROA] of -64.85%, down 7.02 percentage points from FY2024.
- Return on Assets [ROA] has declined for three consecutive years, with a four-year change of -43.74 percentage points (FY2021 to FY2025).
- By year, Return on Assets [ROA] came in at -57.82% in FY2024 (-28.55 pp), -29.27% in FY2023 (-11.16 pp), -18.12% in FY2022 (+2.98 pp) and -21.10% in FY2021.
- Five-year quarterly Return on Assets [ROA] spans a low of -87.37% in Q2 2025 and a high of -16.99% in Q3 2021.
- Year over year, Return on Assets [ROA] gained in two of the last eight quarters, with an average year-over-year change of -23.34 percentage points.
- The high point for year-over-year Return on Assets [ROA] in five years was Q2 2026 (a gain of 9.86 percentage points); the low point was Q2 2025 (a drop of 53.90 percentage points).
- Per Business Quant data, the three quarters before Q2 2026 came in at -74.22% (Q1 2026), -72.03% (Q4 2025) and -86.44% (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROA (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,082.65 Bn | 1,051.23 Bn | 19.71 Bn | 20.64% |
| 2 | Johnson & Johnson | 623.68 Bn | 542.21 Bn | 17.26 Bn | 10.47% |
| 3 | AbbVie | 459.43 Bn | 432.59 Bn | 12.70 Bn | 4.65% |
| 4 | Merck | 354.80 Bn | 309.23 Bn | 12.21 Bn | 2.45% |
| 5 | Novartis Ag | 269.16 Bn | 225.03 Bn | 11.24 Bn | 28.37% |
| 6 | Astrazeneca | 244.40 Bn | 217.97 Bn | 12.86 Bn | 9.10% |
| 7 | Amgen | 220.17 Bn | 175.57 Bn | 7.24 Bn | 9.29% |
| 8 | Gilead Sciences | 183.05 Bn | 157.16 Bn | 6.22 Bn | -6.13% |
| 9 | Pfizer | 160.27 Bn | 107.22 Bn | 10.94 Bn | 2.14% |
| 10 | Lyell Immunopharma | 220.17 Mn | 220.17 Mn | - | -77.52% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -77.52% |
| Mar 31, 2026 | -74.22% |
| Dec 31, 2025 | -72.03% |
| Sep 30, 2025 | -86.44% |
| Jun 30, 2025 | -87.37% |
| Mar 31, 2025 | -78.32% |
| Dec 31, 2024 | -64.64% |
| Sep 30, 2024 | -34.10% |
| Jun 30, 2024 | -33.47% |
| Mar 31, 2024 | -33.24% |
| Dec 31, 2023 | -31.97% |
| Sep 30, 2023 | -24.81% |
| Jun 30, 2023 | -24.44% |
| Mar 31, 2023 | -19.92% |
| Dec 31, 2022 | -19.54% |
| Sep 30, 2022 | -21.99% |
| Jun 30, 2022 | -19.32% |
| Mar 31, 2022 | -20.69% |
| Dec 31, 2021 | -18.43% |
| Sep 30, 2021 | -16.99% |
API Access
Lyell Immunopharma Return on Assets [ROA] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-assets-%5Broa%5D&ticker=LYEL&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-assets-[roa]", "ticker": "LYEL", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-assets-%5Broa%5D&ticker=LYEL&period=max&api_key=YOUR_API_KEY");
const data = await res.json();